Why tocilizumab could be an effective treatment for severe COVID-19?
Commentary
[키워드] acute respiratory distress
acute respiratory distress syndrome (ARDS)
Admission
alveolar
Analysis
ARDS
Autopsy
cause
caused
contribute
COVID-19
COVID-19 patient
died
effective
Gas exchange
high mortality
Host immune response
ICU
IL-6
IL-6 pathway
IL-6 receptor
impede
Inflammatory cytokine storm
inflammatory monocyte
inflammatory storm
intensive care
monoclonal antibody
Mortality
New coronavirus
pathogenic
progressed
public health
Research
Respiratory function
returned
SARS-CoV-2
severe complication
severe COVID-19
severe COVID-19 patients
Severe patient
Spread
suggested
syndrome
T cell
target
temperature
therapeutic
Tocilizumab
Treatment
[DOI] 10.1186/s12967-020-02339-3 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1186/s12967-020-02339-3 PMC 바로가기 [Article Type] Commentary